Table 1.
Characteristic | Intracerebral Hemorrhage (N = 163) | No Intracerebral Hemorrhage (N = 552,406) |
---|---|---|
Age, mean (SD), y | 62.7 (16.8) | 57.5 (16.4) |
Female | 84 (51.5) | 324,170 (58.7) |
Race‡ | ||
White | 68 (43.6) | 237,877 (44.8) |
Black | 53 (34.0) | 154,049 (29.0) |
Hispanic | 21 (13.5) | 94,028 (17.7) |
Asian | 8 (5.1) | 20,937 (4.0) |
Other | 6 (3.9) | 23,600 (4.4) |
Payment source | ||
Medicare | 71 (43.6) | 177,118 (32.1) |
Medicaid | 15 (9.2) | 56,033 (10.2) |
Private insurance | 38 (23.3) | 184,164 (33.4) |
Self-pay | 34 (20.9) | 100,787 (18.3) |
Other | 5 (3.1) | 33,995 (6.2) |
Vascular risk factors | ||
Diabetes | 31 (19.0) | 70,165 (12.7) |
Coronary heart disease | 10 (6.1) | 24,285 (4.4) |
Congestive heart failure | 9 (5.5) | 9,104 (1.7) |
Peripheral vascular disease | 2 (1.2) | 2,387 (0.4) |
Chronic kidney disease | 20 (12.3) | 17,549 (3.2) |
Chronic obstructive pulmonary disease | 3 (1.8) | 8,805 (1.6) |
Atrial fibrillation | 5 (3.1) | 7,490 (1.4) |
Tobacco use | 1 (0.6) | 5,146 (0.9) |
Ethanol abuse | 5 (3.1) | 31,098 (5.6) |
Abbreviations: SD, standard deviation.
Refers to intracerebral hemorrhage diagnoses occurring during days 8-38 after hypertension visit (cohort period) and days 373-403 after hypertension visit (crossover period).
All data are presented as number (%) unless otherwise specified.
Percentages may not add up to 100 because of rounding